VIP (Vasoactive Intestinal Peptide) Dosage Guide

Complete guide to VIP (Vasoactive Intestinal Peptide) dosing protocols, administration methods, and safety considerations for research purposes.

Research Use Only: The dosage information provided is for educational and research purposes. Peptides are not approved by the FDA for human use. Always consult with a healthcare professional.

Recommended Dosage

Intranasal: 50-200mcg 1-3 times daily for chronic inflammatory conditions. Some protocols use subcutaneous administration. Dosing varies by condition.

Administration Method

Intranasal is most common for inflammatory conditions. Subcutaneous injection also used. Must be stored cold and protected from light.

Side Effects to Monitor

May cause nasal irritation, flushing, headache, or temporary diarrhea. Generally well-tolerated at standard doses.

Safety Considerations & Risks

May affect blood pressure due to vasodilatory effects. Limited human research for many applications. Quality and stability concerns.